Novanta Inc.
Financials
Valuation Metrics
Novanta Inc.'s Market Cap is $5.04B. At end of 2025 it was $4.55B. Ranked #1349 of 3,121 in US market (top 43%), #461 of 1,463 on NASDAQ (top 32%), #53 of 99 in Technology Hardware & Equipment (top 54%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.04B | US#1,349/3,121 Sec#53/99 |
| Revenue | $1.03B | US#1,868/3,121 Sec#63/99 |
| Net Income | $62M | US#1,802/3,121 Sec#57/99 |
| Total Assets | $2.14B | US#2,041/3,121 Sec#60/99 |
| Net Assets | $1.62B | US#1,405/3,121 Sec#47/99 |
| Employees | 3,000 | US#1,476/3,121 Sec#58/99 |
| Value | ||
| P/E | 81.52x | US#2,061/3,121 Sec#67/99 |
| P/B | 3.11x | US#1,789/3,121 Sec#40/99 |
| PEG | 124.12x | US#1,299/3,121 Sec#50/99 |
| P/S | 4.89x | US#2,286/3,121 Sec#66/99 |
| EV/EBITDA | 32.95x | US#2,258/3,121 Sec#70/99 |
| FCF Yield | 2.27% | US#1,993/3,121 Sec#55/99 |
| Profitability | ||
| ROE | 3.82% | US#1,902/3,121 Sec#63/99 |
| ROA | 2.89% | US#1,440/3,121 Sec#59/99 |
| Op. Margin | 10.43% | US#1,561/3,121 Sec#42/99 |
| Revenue Growth | 7.61% | US#1,524/3,121 Sec#65/99 |
| Earnings Growth | 0.66% | US#1,287/3,121 Sec#50/99 |
| Financial Health | ||
| Debt Ratio | 32.36% | US#366/3,121 Sec#15/99 |
| Total Debt | $283M | US#2,125/3,121 Sec#47/99 |
| FCF | $114M | US#1,681/3,121 Sec#53/99 |
| Cash | $719M | US#851/3,121 Sec#32/99 |
| Current Ratio | 4.57x | US#525/3,121 Sec#14/99 |
| Net Debt/EBITDA | -3.12x | US#113/3,121 Sec#4/99 |
| Performance | ||
| 1Y Return | 13.58% | US#1,215/3,121 Sec#54/99 |
| 1M Return | -8.77% | US#2,810/3,121 Sec#84/99 |
| From 52W High | -24.52% | US#1,756/3,121 Sec#41/99 |
| 1Y MDD | -26.97% | US#1,186/3,121 Sec#23/99 |
| Trading | ||
| Volume | 646,380 shares | US#2,276/3,121 Sec#74/99 |
| Trading Value | $86M | US#1,272/3,121 Sec#56/99 |
| Per Share | ||
| EPS | $1.63 | US#1,465/3,121 Sec#51/99 |
| BPS | $42.74 | US#560/3,121 Sec#22/99 |
Company Info
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.